Zomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) CEO Larry C. Heaton II acquired 100,000 shares of the business's stock in a transaction dated Thursday, September 5th. The shares were acquired at an average cost of $0.12 per share, with a total value of $12,000.00. Following the transaction, the chief executive officer now owns 400,000 shares in the company, valued at $48,000. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Zomedica Stock Down 0.4 %
Shares of ZOM stock opened at $0.13 on Friday. Zomedica Corp. has a 1 year low of $0.12 and a 1 year high of $0.23. The firm has a market cap of $124.65 million, a PE ratio of -3.20 and a beta of 1.03.
Institutional Investors Weigh In On Zomedica
Hedge funds have recently modified their holdings of the business. Price T Rowe Associates Inc. MD grew its position in shares of Zomedica by 41.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 948,300 shares of the company's stock valued at $139,000 after acquiring an additional 276,100 shares during the period. Frazier Financial Advisors LLC purchased a new position in shares of Zomedica during the 4th quarter valued at $50,000. Finally, Virtu Financial LLC lifted its stake in shares of Zomedica by 1,585.0% during the 1st quarter. Virtu Financial LLC now owns 168,773 shares of the company's stock valued at $25,000 after buying an additional 158,757 shares in the last quarter. Institutional investors own 8.95% of the company's stock.
Zomedica Company Profile
(
Get Free Report)
Elon Musk’s chilling warning for humanity
From The Freeport Society | Ad
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.
Go here to see why.
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
